These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 39012443)

  • 1. An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.
    Akyuz E; Arulsamy A; Aslan FS; Sarisözen B; Guney B; Hekimoglu A; Yilmaz BN; Retinasamy T; Shaikh MF
    Mol Neurobiol; 2024 Jul; ():. PubMed ID: 39012443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.
    Nava-Mesa MO; Jiménez-Díaz L; Yajeya J; Navarro-Lopez JD
    Front Cell Neurosci; 2014; 8():167. PubMed ID: 24987334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.
    Zong B; Yu F; Zhang X; Zhao W; Sun P; Li S; Li L
    Front Aging Neurosci; 2022; 14():869507. PubMed ID: 35663578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2
    Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L
    J Biol Chem; 2021; 296():100089. PubMed ID: 33434745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Bi D; Wen L; Wu Z; Shen Y
    Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.
    Roy J; Tsui KC; Ng J; Fung ML; Lim LW
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
    Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
    Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status and future directions of clinical trials in Alzheimer's disease.
    Plascencia-Villa G; Perry G
    Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms.
    Iliyasu MO; Musa SA; Oladele SB; Iliya AI
    Front Neurosci; 2023; 17():1081938. PubMed ID: 37113145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
    Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
    PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
    Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
    Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
    Nagori K; Pradhan M; Sharma M; Ajazuddin ; Badwaik HR; Nakhate KT
    Curr Alzheimer Res; 2024; 21(1):50-68. PubMed ID: 38529600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.